{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:05:36Z","timestamp":1790841936843,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":91,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372260"],"award-info":[{"award-number":["82372260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Demonstrating Application and Research of Clinical Diagnosis and Treatment Technology in Beijing","award":["Z221100007422002"],"award-info":[{"award-number":["Z221100007422002"]}]},{"name":"Beijing High-Level Innovation and Entrepreneurship Talent Support Program, Young Top Talent Projects","award":["G202522155"],"award-info":[{"award-number":["G202522155"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60553-3","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:27:36Z","timestamp":1783009656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell analyses of liver and blood reveal distinct immune cell signatures of HBV-related HCC patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Yadi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingna","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiguo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"Suppl","key":"60553_CR1","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","volume":"31","author":"SY Hwang","year":"2025","unstructured":"Hwang, S. Y. et al. Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment. Clin. Mol. Hepatol. 31 (Suppl), S228\u2013S254. https:\/\/doi.org\/10.3350\/cmh.2024.0824 (2025).","journal-title":"Clin. Mol. Hepatol."},{"issue":"5","key":"60553_CR2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","volume":"164","author":"MR Toh","year":"2023","unstructured":"Toh, M. R. et al. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology 164 (5), 766\u2013782. https:\/\/doi.org\/10.1053\/j.gastro.2023.01.033 (2023).","journal-title":"Gastroenterology"},{"key":"60553_CR3","doi-asserted-by":"publisher","first-page":"1741620","DOI":"10.3389\/fimmu.2026.1741620","volume":"17","author":"Z Chen","year":"2026","unstructured":"Chen, Z. et al. Innate immune recognition and evasion strategies of hepatitis B virus: from DNA to RNA and viral proteins. Front. Immunol. 17, 1741620. https:\/\/doi.org\/10.3389\/fimmu.2026.1741620 (2026).","journal-title":"Front. Immunol."},{"issue":"1","key":"60553_CR4","doi-asserted-by":"publisher","first-page":"1942673","DOI":"10.1080\/2162402X.2021.1942673","volume":"10","author":"L Yu","year":"2021","unstructured":"Yu, L. et al. TIGIT\u2009+\u2009TIM-3\u2009+\u2009NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus\u2013related hepatocellular carcinoma. Oncoimmunology 10 (1), 1942673. https:\/\/doi.org\/10.1080\/2162402X.2021.1942673 (2021).","journal-title":"Oncoimmunology"},{"issue":"7","key":"60553_CR5","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/ijms20071564","volume":"20","author":"S Hwang","year":"2019","unstructured":"Hwang, S. et al. Cytotoxicity of Human Hepatic Intrasinusoidal CD56bright Natural Killer Cells against Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 20 (7), 1564. https:\/\/doi.org\/10.3390\/ijms20071564 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"60553_CR6","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s42003-025-08443-8","volume":"8","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. Viral-Track integrated single-cell RNA-sequencing reveals HBV lymphotropism and immunosuppressive microenvironment in HBV-associated hepatocellular carcinoma. Commun. Biol. 8 (1), 1030. https:\/\/doi.org\/10.1038\/s42003-025-08443-8 (2025).","journal-title":"Commun. Biol."},{"key":"60553_CR7","doi-asserted-by":"publisher","first-page":"1206720","DOI":"10.3389\/fcimb.2023.1206720","volume":"13","author":"P Zheng","year":"2023","unstructured":"Zheng, P., Dou, Y. & Wang, Q. Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. Front. Cell. Infect. Microbiol. 13, 1206720. https:\/\/doi.org\/10.3389\/fcimb.2023.1206720 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"60553_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy, R. & Pollard, J. W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41 (1), 49\u201361. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.010 (2014).","journal-title":"Immunity"},{"issue":"10","key":"60553_CR9","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.4049\/jimmunol.1201625","volume":"190","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes\/macrophages by interfering with JNK activation. J. Immunol. Baltim. Md. 1950. 190 (10), 5142\u20135151. https:\/\/doi.org\/10.4049\/jimmunol.1201625 (2013).","journal-title":"J. Immunol. Baltim. Md. 1950"},{"issue":"4","key":"60553_CR10","doi-asserted-by":"publisher","first-page":"G459","DOI":"10.1152\/ajpgi.00338.2021","volume":"322","author":"J Li","year":"2022","unstructured":"Li, J. et al. Deacetylation of Notch1 by SIRT1 contributes to HBsAg- and HBeAg-mediated M2 macrophage polarization. Am. J. Physiol. Gastrointest. Liver Physiol. 322 (4), G459\u2013G471. https:\/\/doi.org\/10.1152\/ajpgi.00338.2021 (2022).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"11","key":"60553_CR11","doi-asserted-by":"publisher","first-page":"e0294","DOI":"10.1097\/HC9.0000000000000294","volume":"7","author":"J Bei","year":"2023","unstructured":"Bei, J. et al. HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS\/PDHC hyperacetylation. Hepatol. Commun. 7 (11), e0294. https:\/\/doi.org\/10.1097\/HC9.0000000000000294 (2023).","journal-title":"Hepatol. Commun."},{"issue":"1","key":"60553_CR12","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1038\/s41598-025-89015-y","volume":"15","author":"M Zhou","year":"2025","unstructured":"Zhou, M., Xia, Y. & Wang, S. IL35 modulates HBV-related HCC progression via IL6-STAT3 signaling. Sci. Rep. 15 (1), 6293. https:\/\/doi.org\/10.1038\/s41598-025-89015-y (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"60553_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jcmgh.2022.09.006","volume":"15","author":"Y Makino","year":"2023","unstructured":"Makino, Y. et al. STAT3 is Activated by CTGF-mediated Tumor-stroma Cross Talk to Promote HCC Progression. Cell. Mol. Gastroenterol. Hepatol. 15 (1), 99\u2013119. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.09.006 (2023).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"60553_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3892\/mmr.2020.10991","volume":"21","author":"R Shrestha","year":"2020","unstructured":"Shrestha, R., Bridle, K. R., Crawford, D. H. G. & Jayachandran, A. TNF\u2013\u03b1\u2013mediated epithelial\u2013to\u2013mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinoma. Mol. Med. Rep. 21 (4), 1849\u20131860. https:\/\/doi.org\/10.3892\/mmr.2020.10991 (2020).","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"60553_CR15","first-page":"889","volume":"12","author":"NM Wheelhouse","year":"2003","unstructured":"Wheelhouse, N. M. et al. TNF-alpha induced DNA damage in primary murine hepatocytes. Int. J. Mol. Med. 12 (6), 889\u2013894 (2003).","journal-title":"Int. J. Mol. Med."},{"issue":"15","key":"60553_CR16","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.3390\/ijms22158011","volume":"22","author":"HJ Cho","year":"2021","unstructured":"Cho, H. J. & Cheong, J. Y. Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma. Int. J. Mol. Sci. 22 (15), 8011. https:\/\/doi.org\/10.3390\/ijms22158011 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"60553_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/hep.26668","volume":"59","author":"L Xu","year":"2014","unstructured":"Xu, L., Yin, W., Sun, R., Wei, H. & Tian, Z. Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B virus-persistent mice. Hepatol. Baltim. Md. 59 (2), 443\u2013452. https:\/\/doi.org\/10.1002\/hep.26668 (2014).","journal-title":"Hepatol. Baltim. Md."},{"issue":"2","key":"60553_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3892\/ijmm.2018.3688","volume":"42","author":"H Cao","year":"2018","unstructured":"Cao, H., Zhang, R. & Zhang, W. CTLA\u20134 interferes with the HBV\u2013specific T cell immune response (Review). Int. J. Mol. Med. 42 (2), 703\u2013712. https:\/\/doi.org\/10.3892\/ijmm.2018.3688 (2018).","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"60553_CR19","first-page":"422","volume":"115","author":"R Jiang","year":"2002","unstructured":"Jiang, R. et al. T helper cells in patients with chronic hepatitis B virus infection. Chin. Med. J. (Engl). 115 (3), 422\u2013424 (2002).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"15","key":"60553_CR20","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1016\/j.cell.2024.05.038","volume":"187","author":"F Andreata","year":"2024","unstructured":"Andreata, F. et al. Therapeutic potential of co-signaling receptor modulation in hepatitis B. Cell 187 (15), 4078\u20134094e21. https:\/\/doi.org\/10.1016\/j.cell.2024.05.038 (2024).","journal-title":"Cell"},{"key":"60553_CR21","doi-asserted-by":"publisher","first-page":"923031","DOI":"10.3389\/fimmu.2022.923031","volume":"13","author":"J Jia","year":"2022","unstructured":"Jia, J. et al. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma. Front. Immunol. 13, 923031. https:\/\/doi.org\/10.3389\/fimmu.2022.923031 (2022).","journal-title":"Front. Immunol."},{"issue":"4","key":"60553_CR22","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.gastro.2017.06.017","volume":"153","author":"G Zhou","year":"2017","unstructured":"Zhou, G. et al. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Gastroenterology 153 (4), 1107\u20131119e10. https:\/\/doi.org\/10.1053\/j.gastro.2017.06.017 (2017).","journal-title":"Gastroenterology"},{"key":"60553_CR23","doi-asserted-by":"publisher","unstructured":"Lin, N. et al. The role of regulatory T cells and follicular T helper cells in HBV infection. Front. Immunol. 14 https:\/\/doi.org\/10.3389\/fimmu.2023.1169601 (2023).","DOI":"10.3389\/fimmu.2023.1169601"},{"issue":"7","key":"60553_CR24","doi-asserted-by":"publisher","first-page":"e0071125","DOI":"10.1128\/jvi.00711-25","volume":"99","author":"C Rexhouse","year":"2025","unstructured":"Rexhouse, C., Bailey, J. T., Moshkani, S., Cimino, J. L. & Robek, M. D. High antigen burden drives CD8\u2009+\u2009T cell dysfunction in a mouse model of chronic hepatitis B virus infection. J. Virol. 99 (7), e0071125. https:\/\/doi.org\/10.1128\/jvi.00711-25 (2025).","journal-title":"J. Virol."},{"issue":"6","key":"60553_CR25","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1136\/gutjnl-2022-328428","volume":"72","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences. Gut 72 (6), 1196\u20131210. https:\/\/doi.org\/10.1136\/gutjnl-2022-328428 (2023).","journal-title":"Gut"},{"issue":"22","key":"60553_CR26","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3748\/wjg.v27.i22.2994","volume":"27","author":"A Granito","year":"2021","unstructured":"Granito, A. et al. Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4\u2009+\u2009CD25+ Foxp3\u2009+\u2009regulatory T cells in the immune microenvironment. World J. Gastroenterol. 27 (22), 2994\u20133009. https:\/\/doi.org\/10.3748\/wjg.v27.i22.2994 (2021).","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"60553_CR27","doi-asserted-by":"publisher","first-page":"910","DOI":"10.7150\/thno.35045","volume":"10","author":"O Lo Re","year":"2020","unstructured":"Lo Re, O. et al. Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4\u2009+\u2009CD25+FoxP3\u2009+\u2009regulatory T cells activation. Theranostics 10 (2), 910\u2013924. https:\/\/doi.org\/10.7150\/thno.35045 (2020).","journal-title":"Theranostics"},{"issue":"7","key":"60553_CR28","doi-asserted-by":"publisher","first-page":"e187025","DOI":"10.1172\/jci.insight.187025","volume":"10","author":"SY Neo","year":"2025","unstructured":"Neo, S. Y. et al. Atypical memory B cells acquire Breg phenotypes in hepatocellular carcinoma. JCI Insight. 10 (7), e187025. https:\/\/doi.org\/10.1172\/jci.insight.187025 (2025).","journal-title":"JCI Insight"},{"key":"60553_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/JHC.S159693","volume":"6","author":"LC Lu","year":"2019","unstructured":"Lu, L. C., Chang, C. J. & Hsu, C. H. Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives. J. Hepatocell Carcinoma. 6, 71\u201384. https:\/\/doi.org\/10.2147\/JHC.S159693 (2019).","journal-title":"J. Hepatocell Carcinoma"},{"issue":"1","key":"60553_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12964-025-02170-7","volume":"23","author":"X Liu","year":"2025","unstructured":"Liu, X., Kang, X., Kang, H. & Yan, H. The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities. Cell. Commun. Signal. CCS. 23 (1), 155. https:\/\/doi.org\/10.1186\/s12964-025-02170-7 (2025).","journal-title":"Cell. Commun. Signal. CCS"},{"issue":"1","key":"60553_CR31","doi-asserted-by":"publisher","first-page":"189517","DOI":"10.1016\/j.bbcan.2025.189517","volume":"1881","author":"Z Zhang","year":"2026","unstructured":"Zhang, Z. et al. Fibrosis-driven hepatocarcinogenesis, metastasis and immune evasion: Mechanisms and therapeutic targets. Biochim. Biophys. Acta Rev. Cancer. 1881 (1), 189517. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189517 (2026).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"60553_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero, J. A. et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatol. Baltim. Md. 68 (2), 723\u2013750. https:\/\/doi.org\/10.1002\/hep.29913 (2018).","journal-title":"Hepatol. Baltim. Md."},{"issue":"2","key":"60553_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia, F., Perego, M. & Gabrilovich, D. Myeloid-derived suppressor cells coming of age. Nat. Immunol. 19 (2), 108\u2013119. https:\/\/doi.org\/10.1038\/s41590-017-0022-x (2018).","journal-title":"Nat. Immunol."},{"key":"60553_CR34","doi-asserted-by":"publisher","first-page":"101435","DOI":"10.1016\/j.smim.2020.101435","volume":"49","author":"J Han","year":"2020","unstructured":"Han, J., Khatwani, N., Searles, T. G., Turk, M. J. & Angeles, C. V. Memory CD8\u2009+\u2009T cell responses to cancer. Semin Immunol. 49, 101435. https:\/\/doi.org\/10.1016\/j.smim.2020.101435 (2020).","journal-title":"Semin Immunol."},{"issue":"10","key":"60553_CR35","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/s43018-024-00824-y","volume":"5","author":"X Qiu","year":"2024","unstructured":"Qiu, X. et al. Spatial single-cell protein landscape reveals vimentinhigh macrophages as immune-suppressive in the microenvironment of hepatocellular carcinoma. Nat. Cancer. 5 (10), 1557\u20131578. https:\/\/doi.org\/10.1038\/s43018-024-00824-y (2024).","journal-title":"Nat. Cancer"},{"issue":"4","key":"60553_CR36","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell 179 (4), 829\u2013845e20. https:\/\/doi.org\/10.1016\/j.cell.2019.10.003 (2019).","journal-title":"Cell"},{"key":"60553_CR37","doi-asserted-by":"publisher","first-page":"1194199","DOI":"10.3389\/fcell.2023.1194199","volume":"11","author":"J Gao","year":"2023","unstructured":"Gao, J. et al. Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma. Front. Cell. Dev. Biol. 11, 1194199. https:\/\/doi.org\/10.3389\/fcell.2023.1194199 (2023).","journal-title":"Front. Cell. Dev. Biol."},{"key":"60553_CR38","doi-asserted-by":"publisher","first-page":"104997","DOI":"10.1016\/j.critrevonc.2025.104997","volume":"216","author":"K Rahi","year":"2025","unstructured":"Rahi, K., Hedayati, M., Hendi, Z., Najimi, M. & Vosough, M. Liver microenvironment and therapy resistance in hepatocellular carcinoma. Crit. Rev. Oncol. Hematol. 216, 104997. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104997 (2025).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"60553_CR39","unstructured":"S100A9\u2009+\u2009CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function - PubMed. Accessed October 16. (2025). https:\/\/pubmed.ncbi.nlm.nih.gov\/38454445\/"},{"issue":"4","key":"60553_CR40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li, H. et al. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma. Cell 176 (4), 775\u2013789e18. https:\/\/doi.org\/10.1016\/j.cell.2018.11.043 (2019).","journal-title":"Cell"},{"key":"60553_CR41","doi-asserted-by":"publisher","unstructured":"Bouguerra, R. et al. Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy. Hepatol Baltim. Md Published online Oct. 23 https:\/\/doi.org\/10.1097\/HEP.0000000000001575 (2025).","DOI":"10.1097\/HEP.0000000000001575"},{"issue":"3","key":"60553_CR42","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s12072-013-9445-0","volume":"7","author":"LJ Chen","year":"2013","unstructured":"Chen, L. J., Lv, J., Wen, X. Y. & Niu, J. Q. CXC chemokine IP-10: a key actor in liver disease? Hepatol. Int. 7 (3), 798\u2013804. https:\/\/doi.org\/10.1007\/s12072-013-9445-0 (2013).","journal-title":"Hepatol. Int."},{"issue":"738","key":"60553_CR43","doi-asserted-by":"publisher","first-page":"eadm8859","DOI":"10.1126\/scitranslmed.adm8859","volume":"16","author":"P Ho","year":"2024","unstructured":"Ho, P. et al. Harnessing regulatory T cells to establish immune tolerance. Sci. Transl Med. 16 (738), eadm8859. https:\/\/doi.org\/10.1126\/scitranslmed.adm8859 (2024).","journal-title":"Sci. Transl Med."},{"issue":"10","key":"60553_CR44","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1172\/JCI68189","volume":"123","author":"JD Waight","year":"2013","unstructured":"Waight, J. D. et al. Myeloid-derived suppressor cell development is regulated by a STAT\/IRF-8 axis. J. Clin. Invest. 123 (10), 4464\u20134478. https:\/\/doi.org\/10.1172\/JCI68189 (2013).","journal-title":"J. Clin. Invest."},{"issue":"8","key":"60553_CR45","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia, F., Sanseviero, E. & Gabrilovich, D. I. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol. 21 (8), 485\u2013498. https:\/\/doi.org\/10.1038\/s41577-020-00490-y (2021).","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"60553_CR46","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1016\/j.ccell.2024.10.008","volume":"42","author":"C Yang","year":"2024","unstructured":"Yang, C. et al. Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy. Cancer Cell. 42 (12), 2064\u20132081e19. https:\/\/doi.org\/10.1016\/j.ccell.2024.10.008 (2024).","journal-title":"Cancer Cell."},{"issue":"5","key":"60553_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","volume":"21","author":"S Kumagai","year":"2024","unstructured":"Kumagai, S., Itahashi, K. & Nishikawa, H. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine. Nat. Rev. Clin. Oncol. 21 (5), 337\u2013353. https:\/\/doi.org\/10.1038\/s41571-024-00870-6 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"60553_CR48","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","volume":"21","author":"S Kumagai","year":"2020","unstructured":"Kumagai, S. et al. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies. Nat. Immunol. 21 (11), 1346\u20131358. https:\/\/doi.org\/10.1038\/s41590-020-0769-3 (2020).","journal-title":"Nat. Immunol."},{"issue":"2","key":"60553_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1158\/2326-6066.CIR-22-0277","volume":"11","author":"BL Xiao","year":"2023","unstructured":"Xiao, B. L. et al. HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy. Cancer Immunol. Res. 11 (2), 228\u2013240. https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0277 (2023).","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"60553_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","volume":"22","author":"M Iannacone","year":"2022","unstructured":"Iannacone, M. & Guidotti, L. G. Immunobiology and pathogenesis of hepatitis B virus infection. Nat. Rev. Immunol. 22 (1), 19\u201332. https:\/\/doi.org\/10.1038\/s41577-021-00549-4 (2022).","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"60553_CR51","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","volume":"50","author":"MT Chow","year":"2019","unstructured":"Chow, M. T. et al. Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy. Immunity 50 (6), 1498\u20131512e5. https:\/\/doi.org\/10.1016\/j.immuni.2019.04.010 (2019).","journal-title":"Immunity"},{"issue":"4","key":"60553_CR52","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000542578","volume":"14","author":"Y Lin","year":"2025","unstructured":"Lin, Y. et al. Immunometabolic Targets in CD8\u2009+\u2009T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma. Liver Cancer. 14 (4), 474\u2013496. https:\/\/doi.org\/10.1159\/000542578 (2025).","journal-title":"Liver Cancer"},{"issue":"11","key":"60553_CR53","doi-asserted-by":"publisher","first-page":"e70338","DOI":"10.1111\/liv.70338","volume":"45","author":"M Garc\u00eda-L\u00f3pez","year":"2025","unstructured":"Garc\u00eda-L\u00f3pez, M. et al. HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T Cells. Liver Int. Off J. Int. Assoc. Study Liver. 45 (11), e70338. https:\/\/doi.org\/10.1111\/liv.70338 (2025).","journal-title":"Liver Int. Off J. Int. Assoc. Study Liver"},{"issue":"1","key":"60553_CR54","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1038\/s41467-022-33116-z","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang, L. et al. Inhibition of UBA6 by inosine augments tumour immunogenicity and responses. Nat. Commun. 13 (1), 5413. https:\/\/doi.org\/10.1038\/s41467-022-33116-z (2022).","journal-title":"Nat. Commun."},{"issue":"1","key":"60553_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/gutjnl-2021-325915","volume":"72","author":"C Zhang","year":"2023","unstructured":"Zhang, C. et al. Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients. Gut 72 (1), 153\u2013167. https:\/\/doi.org\/10.1136\/gutjnl-2021-325915 (2023).","journal-title":"Gut"},{"issue":"1","key":"60553_CR56","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12072-024-10753-8","volume":"19","author":"D Zhu","year":"2025","unstructured":"Zhu, D. et al. Functional B cell deficiency promotes intrahepatic HBV replication and impairs the development of anti-HBV T cell responses. Hepatol. Int. 19 (1), 93\u2013105. https:\/\/doi.org\/10.1007\/s12072-024-10753-8 (2025).","journal-title":"Hepatol. Int."},{"issue":"1","key":"60553_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41421-023-00563-x","volume":"9","author":"H He","year":"2023","unstructured":"He, H. et al. Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. Cell. Discov. 9 (1), 60. https:\/\/doi.org\/10.1038\/s41421-023-00563-x (2023).","journal-title":"Cell. Discov"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60553-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60553-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:53:14Z","timestamp":1790841194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60553-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60553"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60553-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethical committee of Beijing You\u2019an Hospital, Capital Medical University (No. LL-2020-160-K, Jingyou Kelun Zi [2020] No. 129). We confirmed that all experiments were performed in accordance with relevant guidelines, regulations and the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Informed consent st<b>atement<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"30455"}}